On Monday, Shares of American Eagle Outfitters (NYSE:AEO), subtract -0.99% and closed at $17.02 in the last trading session. AEO stock opened its last trade at $17.04 and after floating in a range of $17.01 to $17.28. The company’s Market capitalization is $3.07 Billion with the total Outstanding Shares of 181.76 million. During the 52-week trading session the minimum price at which share price traded, registered at $12.78 and reached to max level of $19.55. American Eagle Outfitters, Inc. operates as a specialty retailer offering on-trend clothing, accessories, and personal care products under the American Eagle Outfitters and Aerie brands. The company provides denim, bottoms, and other apparel, in addition to footwear and accessories for men and women; and intimates, counting bras, undies, swim, and other products, in addition to apparel and personal care products for women. In addition, it offers sports apparel under the Tailgate brand; and menswear products under the Todd Snyder New York brand name. The company operates about 1,000 stores in the United States, Canada, Mexico, China, Hong Kong, and the United Kingdom, and ships to 81 countries through its websites. It also offers its merchandise at 151 stores operated by licensees in 22 countries, in addition to through its Websites at ae.com, aerie.com, TailgateClothing.com, and ToddSnyder.com.
GlaxoSmithKline plc (ADR)(NYSE:GSK), dropped -1.21% and closed at $41.19 in the last trading session. GSK stock opened its last trade at $41.31 and after floating in a range of $41.19 to $41.50. The company’s Market capitalization is $98.15 Billion with the total Outstanding Shares of 4.87 Billion. During the 52-week trading session the minimum price at which share price traded, registered at $37.81 and reached to max level of $45.58. GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, counting vaccines, over-the-counter medicines, and health-related consumer products worldwide. The company offers pharmaceutical products in the therapeutic areas, counting respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, and emesis, dermatology, rare diseases, immuno-inflammation, vaccines, and HIV. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health areas. The companys wellness products include Panadol and Panadol Cold & Flu for headache, joint pain, fever, and cold symptoms; ENO and Tums that are immediate relief antacids; and Nicorette (US), Nicoderm, NiQuitin CQ, and Nicabate for the treatment of nicotine withdrawal as an aid to smoking reduction and cessation. Its oral health products comprise Sensodyne to treat and prevent dental sensitivity and acid erosion; Polident, Poligrip, and Corega to enhance comfort of fitted dentures and to clean dentures; and Aquafresh for the prevention of caries, gum disease, and bad breath. The companys nutrition products include Horlicks, a nutritional beverages and food; and skin health products comprise Physiogel, a face and body care product for dry, sensitive, and irritated skin, in addition to Zovirax and Abreva to treat and prevent the onset of cold sores. GlaxoSmithKline plc has partnershipagreements with Université de Sherbrooke and Pfizer Inc.; development agreement, and R and D partnershipwith Propeller Health; R and D partnershipagreement with Valneva SE; and partnershipand license agreement with Idera pharmaceuticals, Inc.